DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.
-
Upload
tiffany-lillian-perkins -
Category
Documents
-
view
231 -
download
3
Transcript of DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.
![Page 1: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/1.jpg)
DERMATITISDERMATITIS
Dr. Ruth WestraDr. Ruth Westra
June 4, 2008June 4, 2008
![Page 2: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/2.jpg)
TYPES OF DERMATITISTYPES OF DERMATITIS
Atopic Dermatitis (Eczema)Atopic Dermatitis (Eczema) Contact DermatitisContact Dermatitis Seborrheic DermatitisSeborrheic Dermatitis Stasis DermatitisStasis Dermatitis PhotodermatitisPhotodermatitis MultifactorialMultifactorial
![Page 3: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/3.jpg)
ATOPIC DERMATITISATOPIC DERMATITIS
Chronic, pruritic eczematous Chronic, pruritic eczematous condition of the skin that is condition of the skin that is associated with a personal or family associated with a personal or family history of atopic disease (asthma, history of atopic disease (asthma, allergic rhinitis)allergic rhinitis)
Etiology unknownEtiology unknown
![Page 4: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/4.jpg)
![Page 5: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/5.jpg)
![Page 6: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/6.jpg)
INCIDENCE OF ATOPIC INCIDENCE OF ATOPIC DERMATITISDERMATITIS
Disease of childhood – 10% of Disease of childhood – 10% of children affected in U.S.children affected in U.S.
Uncommon for adults to develop Uncommon for adults to develop atopic dermatitis without a history of atopic dermatitis without a history of eczema in childhoodeczema in childhood
![Page 7: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/7.jpg)
EPIDEMIOLOGY OF ATOPIC EPIDEMIOLOGY OF ATOPIC DERMATITISDERMATITIS
Increased prevalence may be due to Increased prevalence may be due to exposure to pollutants, indoor exposure to pollutants, indoor allergens, and decline in breast allergens, and decline in breast feedingfeeding
?Autosomal dominant gene?Autosomal dominant gene
![Page 8: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/8.jpg)
ALLERGENS FOR A.D.ALLERGENS FOR A.D.
Food allergensFood allergens AeroallergensAeroallergens MicrobesMicrobes
![Page 9: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/9.jpg)
CLINICAL FEATURES OF CLINICAL FEATURES OF ATOPIC DERMATITISATOPIC DERMATITIS
PruritisPruritis Facial and Extensor Papulovesicles in Facial and Extensor Papulovesicles in
InfancyInfancy Flexural Lichenification in Adults and Flexural Lichenification in Adults and
Older ChildrenOlder Children Chronic-relapsing CourseChronic-relapsing Course Personal or Family History of Atopic DxPersonal or Family History of Atopic Dx
![Page 10: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/10.jpg)
TABLE 1 Diagnostic Features of Atopic Dermatitis*
Major features Pruritus Chronic or relapsing dermatitis Personal or family history of atopic disease Typical distribution and morphology of atopic dermatitis rash:
Facial and extensor surfaces in infants and young children Flexure lichenification in older children and adults
Minor features Eyes
Cataracts (anterior subcapsular) Keratoconus Infraorbital folds affected
Facial pallor Palmar hyperlinearity Xerosis Pityriasis alba White dermatographism Ichthyosis Keratosis pilaris Nonspecific dermatitis of the hands and feet Nipple eczema Positive type I hypersensitivity skin tests Propensity for cutaneous infections Elevated serum IgE level Food intolerance Impaired cell-mediated immunity Erythroderma Early age of onset *--The diagnosis of atopic dermatitis should be suspected if three major criteria and three minor criteria are present.
![Page 11: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/11.jpg)
DIFFERENTIAL DIAGNOIS OF DIFFERENTIAL DIAGNOIS OF A.D.A.D.
Congenital DisordersCongenital Disorders Chronic DermatosesChronic Dermatoses Infections and InfestationsInfections and Infestations Malignancies Malignancies ImmunodeficienciesImmunodeficiencies Metabolic DisordersMetabolic Disorders Immunologic DisordersImmunologic Disorders
![Page 12: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/12.jpg)
TREATMENT FOR A.D.TREATMENT FOR A.D.
Cutaneous hydrationCutaneous hydration Topical Glucocorticoid RxTopical Glucocorticoid Rx Identify and Eliminate Flare FactorsIdentify and Eliminate Flare Factors
![Page 13: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/13.jpg)
NEW RXNEW RX
Protopic (tacrolimus),topical Protopic (tacrolimus),topical immunomodulator, inhibits T-cell immunomodulator, inhibits T-cell activation by preventing transcription activation by preventing transcription of early cytokines (CREAM)of early cytokines (CREAM)
Elidel (pimecrolimus), a calcineurin Elidel (pimecrolimus), a calcineurin inhibitorinhibitor
Both for short-term and intermittent Both for short-term and intermittent long-term therapy without occlusive long-term therapy without occlusive dressingsdressings
![Page 14: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/14.jpg)
![Page 15: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/15.jpg)
TREATMENT OF PRURITISTREATMENT OF PRURITIS
AntihistaminesAntihistamines Tar PreparationsTar Preparations
![Page 16: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/16.jpg)
ELIMINATE AGGRAVATING ELIMINATE AGGRAVATING FACTORSFACTORS
Specific allergensSpecific allergens Emotional StressorsEmotional Stressors Infectious AgentsInfectious Agents
![Page 17: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/17.jpg)
POORLY CONTROLLED A.D.POORLY CONTROLLED A.D.
Wet Dressings and OcclusionWet Dressings and Occlusion Systemic GlucocorticoidsSystemic Glucocorticoids Ultraviolet Light (PUVA)Ultraviolet Light (PUVA) Leukotriene InhibitorsLeukotriene Inhibitors Immunosuppressants and Immunosuppressants and
AnitneoplasticsAnitneoplastics HospitalizationHospitalization
![Page 18: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/18.jpg)
COMPLICATIONS OF ATOPIC COMPLICATIONS OF ATOPIC DERMATITISDERMATITIS
EyeEye InfectionsInfections Hand DermatitisHand Dermatitis Exfoliative DermatitisExfoliative Dermatitis
![Page 19: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/19.jpg)
PROGNOSISPROGNOSIS
Spontaneous resolution after age 5 in 40%Spontaneous resolution after age 5 in 40% 84% of children “outgrow” by adolescents84% of children “outgrow” by adolescents Predictive factors of Poor Prognosis Predictive factors of Poor Prognosis
Wide spread AD in childhood Wide spread AD in childhood Associated allergic rhinitis or asthma Associated allergic rhinitis or asthma Early age at onset of AD and female sex Early age at onset of AD and female sex Family history of AD in parents or siblings Family history of AD in parents or siblings
![Page 20: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/20.jpg)
![Page 21: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/21.jpg)
![Page 22: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/22.jpg)
![Page 23: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/23.jpg)
![Page 24: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/24.jpg)
![Page 25: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/25.jpg)
![Page 26: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/26.jpg)
![Page 27: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/27.jpg)
![Page 28: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/28.jpg)
CONTACT DERMATITISCONTACT DERMATITIS
Inflammatory reaction of the skin Inflammatory reaction of the skin precipitated by an exogenous chemicalprecipitated by an exogenous chemical
Two types of contact dermatitis Two types of contact dermatitis Irritant - direct toxic effect on the Irritant - direct toxic effect on the skin Allergic - immunologic reaction skin Allergic - immunologic reaction that causes tissue inflammation (Type that causes tissue inflammation (Type IV Hypersensitivity)IV Hypersensitivity)
![Page 29: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/29.jpg)
INCIDENCE OF CONTACT INCIDENCE OF CONTACT DERMATITISDERMATITIS
Environmental AllergensEnvironmental Allergens Occupationally related illnessOccupationally related illness
![Page 30: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/30.jpg)
SENSITIZERS OF CONTACT SENSITIZERS OF CONTACT DERMATITISDERMATITIS
Poison IvyPoison Ivy ParaphenylenediamineParaphenylenediamine NickelNickel Rubber CompoundsRubber Compounds EthylenediamineEthylenediamine
![Page 33: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/33.jpg)
CLINICAL FEATURES OF CLINICAL FEATURES OF CONTACT DERMATITISCONTACT DERMATITIS
Acute – linear streaks of vesiclesAcute – linear streaks of vesicles Chronic - lichenification, eczematous Chronic - lichenification, eczematous
reactionreaction
![Page 34: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/34.jpg)
LOCATION OF CONTACT LOCATION OF CONTACT DERMATITISDERMATITIS
Head and neck-cosmeticsHead and neck-cosmetics Scalp-hair dyes, permanents and Scalp-hair dyes, permanents and
shampoosshampoos Eyelids-eye cosmetics and nail polishEyelids-eye cosmetics and nail polish Dorsum of hands-industrial chemicalsDorsum of hands-industrial chemicals Dorsum of feet-shoes, rubber, leatherDorsum of feet-shoes, rubber, leather
![Page 35: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/35.jpg)
DIFFERENTIAL DIAGNOSIS DIFFERENTIAL DIAGNOSIS OF CONTACT DERMATITISOF CONTACT DERMATITIS
Atopic DermatitsAtopic Dermatits Seborrheic DermatitisSeborrheic Dermatitis Stasis DermatitisStasis Dermatitis Fungal InfectionsFungal Infections Bacterial CellulitisBacterial Cellulitis
![Page 36: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/36.jpg)
LABORATORYLABORATORY
No testing for Irritant Contact No testing for Irritant Contact DermatitisDermatitis
Patch Testing for Allergic Contact Patch Testing for Allergic Contact Dermatitis - North American Contact Dermatitis - North American Contact Dermatitis Group Standard Patch Dermatitis Group Standard Patch Test SeriesTest Series
![Page 38: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/38.jpg)
MOST FREQUENT MOST FREQUENT ALLERGENSALLERGENS
Nickel sulfateNickel sulfate Quaternium-15Quaternium-15 Fragrance mixFragrance mix BacitracinBacitracin Neomycin sulfateNeomycin sulfate CobaltCobalt Balsam of PeruBalsam of Peru Para-Para-
phenylenediaminephenylenediamine ThimerosolThimerosol Thiuram mixThiuram mix FormaldehydeFormaldehyde Carba mixCarba mix
![Page 39: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/39.jpg)
TREATMENT FOR CONTACT TREATMENT FOR CONTACT DERMATITISDERMATITIS
Prevention-Allergen AvoidancePrevention-Allergen Avoidance Symptomatic TherapySymptomatic Therapy Physicochemical BarriersPhysicochemical Barriers Tolerance InductionTolerance Induction
![Page 40: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/40.jpg)
![Page 41: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/41.jpg)
![Page 42: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/42.jpg)
![Page 45: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/45.jpg)
![Page 46: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/46.jpg)
![Page 47: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/47.jpg)
![Page 48: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/48.jpg)
SEBORRHIEC DERMATITISSEBORRHIEC DERMATITIS
Chronic, superficial inflammatory process Chronic, superficial inflammatory process affecting the hairy regions of the body affecting the hairy regions of the body (scalp, eyebrows and face especially)(scalp, eyebrows and face especially)
Affects infants and adultsAffects infants and adults Wide range from mild to severeWide range from mild to severe One of most common skin manifestations One of most common skin manifestations
in patients with HIV infectionin patients with HIV infection
![Page 50: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/50.jpg)
INCIDENCE OF SEBORRHEIC INCIDENCE OF SEBORRHEIC DERMATITISDERMATITIS
Two peaks - Infancy in the first 3 Two peaks - Infancy in the first 3 months Adult in the fourth to months Adult in the fourth to seventh decadeseventh decade
In adults more common than psoriasis In adults more common than psoriasis 2-5% of the population 2-5% of the population
Men affected more than womenMen affected more than women 85% incidence in HIV infection 85% incidence in HIV infection
patientspatients
![Page 51: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/51.jpg)
ETIOLOGY OF SEBORRHEIC ETIOLOGY OF SEBORRHEIC DERMATITISDERMATITIS
UnknownUnknown Associated with oily-looking skin but Associated with oily-looking skin but
not a disease of the sebaceous glandnot a disease of the sebaceous gland Associated with Parkinson’s DiseaseAssociated with Parkinson’s Disease
![Page 52: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/52.jpg)
CLINICAL FEATURES OF CLINICAL FEATURES OF SEBORRHEIC DERMATITISSEBORRHEIC DERMATITIS
Bilateral and SymmetricalBilateral and Symmetrical Predilection for Hairy Regions Predilection for Hairy Regions Patches and Plaques with indistinct Patches and Plaques with indistinct
marginsmargins Uncommon to have hair loss Uncommon to have hair loss
![Page 53: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/53.jpg)
CLINICAL FEATURES OF S.D.CLINICAL FEATURES OF S.D.
Infantile Infantile Scalp (cradle cap) Scalp (cradle cap) Trunk (including flexures Trunk (including flexures and diaper area) Leiner’s disease and diaper area) Leiner’s disease (non-familial and Familial (non-familial and Familial Complement 5 dysfunction)Complement 5 dysfunction)
![Page 54: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/54.jpg)
CLINICAL FEATURES OF S.D.CLINICAL FEATURES OF S.D.
Adult Adult Scalp Scalp Face Face Trunk - Trunk - Petaloid, Pityriasiform, Flexural, Petaloid, Pityriasiform, Flexural, Eczematous plaques, Follicular Eczematous plaques, Follicular Generalized Generalized
![Page 55: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/55.jpg)
FIGURE 7. Typical symmetrical distribution of seborrheic dermatitis on the head (top), and on the body (bottom).
![Page 56: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/56.jpg)
DIFFERENTIAL DIAGNOSISDIFFERENTIAL DIAGNOSISSEBORRHEIC DERMATITISSEBORRHEIC DERMATITIS
Atopic DermatitisAtopic Dermatitis PsoriasisPsoriasis Tinea CapitisTinea Capitis SLESLE RosaceaRosacea Histiocytosis XHistiocytosis X
![Page 57: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/57.jpg)
DRUGS CAUSING S.D. RASHDRUGS CAUSING S.D. RASH
Produce Seborrheic Dermatitis like Produce Seborrheic Dermatitis like lesions Arsenic lesions Arsenic Gold Gold Methyldopa Methyldopa Cimetidine Cimetidine NeurolepticsNeuroleptics
![Page 58: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/58.jpg)
NEUROLOGIC NEUROLOGIC ABNORMALITIES AND S.D.ABNORMALITIES AND S.D.
Variety of Neurologic Abnormalities Variety of Neurologic Abnormalities associated with seborrheic dermatitis associated with seborrheic dermatitis Parkinson’s Disease Parkinson’s Disease Facial Paralysis Facial Paralysis Poliomyelitis Poliomyelitis Quadriplegia Quadriplegia
EpilepsyEpilepsy
![Page 59: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/59.jpg)
PHYSICAL FACTORSPHYSICAL FACTORS
Seasonal variationSeasonal variation Relation to PUVARelation to PUVA
![Page 60: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/60.jpg)
IMMUNODEFICIENCY AND IMMUNODEFICIENCY AND S.D.S.D.
Clue to the presence of HIV Clue to the presence of HIV Distribution is extensive, severity Distribution is extensive, severity remarkable and treatment often remarkable and treatment often difficultdifficult
![Page 61: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/61.jpg)
TREATMENT GOALS OF S.D.TREATMENT GOALS OF S.D.
Loosening and removal of scales and Loosening and removal of scales and crustscrusts
Inhibition of yeast colonizationInhibition of yeast colonization Control of secondary infectionControl of secondary infection Reduction of erythema and itchingReduction of erythema and itching Control rather than cureControl rather than cure
![Page 62: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/62.jpg)
TREATMENT FOR INFANTSTREATMENT FOR INFANTS
Scalp Scalp Removal of crusts with 3-5% Removal of crusts with 3-5% salicylic acid in olive oil or water salicylic acid in olive oil or water soluble base Warm olive oil soluble base Warm olive oil compresses compresses Application of low potency Application of low potency glucocorticoids Mild baby shampoosglucocorticoids Mild baby shampoos
![Page 63: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/63.jpg)
TREATMENT FOR INFANTSTREATMENT FOR INFANTS
Intertriginous areas Intertriginous areas Drying lotions (0.2-0.5% Drying lotions (0.2-0.5% clioquinol in zinc lotion or zinc oil) clioquinol in zinc lotion or zinc oil) Candidiasis- Candidiasis- Nystatin Cream Nystatin Cream
Gentian Violet 0.1-0.25% if oozing Gentian Violet 0.1-0.25% if oozing
![Page 64: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/64.jpg)
TREATMENT OF ADULTSTREATMENT OF ADULTS
Chronic Condition Chronic Condition
Anti-inflammatory Anti-inflammatory Anti- Anti-fungal fungal KerolyticsKerolytics
![Page 65: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/65.jpg)
TREATMENT OF ADULTSTREATMENT OF ADULTS
Scalp - Daily Shampoo containing 1-2.5% Scalp - Daily Shampoo containing 1-2.5% selenium sulfide, antifungals, zinc, selenium sulfide, antifungals, zinc, benzoyl peroxide, salicylic acid, coal or benzoyl peroxide, salicylic acid, coal or juniper tarjuniper tar
Crusts - can be removed by overnight Crusts - can be removed by overnight application of topical glucocorticoids or application of topical glucocorticoids or salicylic acid in water soluble basesalicylic acid in water soluble base
Tinctures and alcoholic solutions in hair Tinctures and alcoholic solutions in hair tonics aggravatetonics aggravate
![Page 66: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/66.jpg)
TREATMENT OF ADULTSTREATMENT OF ADULTS
Face and trunk - low potency Face and trunk - low potency glucocorticoids (1% hydrocortisone) glucocorticoids (1% hydrocortisone)
Avoid greasy ointments Avoid greasy ointments Lotion – Cream – Ointment Lotion – Cream – Ointment
(strongest)(strongest)
![Page 67: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/67.jpg)
TREATMENT OF ADULTSTREATMENT OF ADULTS
Anti-fungals - Imidazoles Anti-fungals - Imidazoles 95% improvement with 95% improvement with ketaconazole inhibition of cell ketaconazole inhibition of cell wall synthesis no proof of wall synthesis no proof of fungal etiologyfungal etiology
Metronidazole - topical 0.75% gel Metronidazole - topical 0.75% gel (Metrogel) some improvement(Metrogel) some improvement
![Page 68: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/68.jpg)
![Page 69: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/69.jpg)
![Page 70: DERMATITIS Dr. Ruth Westra Dr. Ruth Westra June 4, 2008.](https://reader035.fdocuments.net/reader035/viewer/2022081512/56649e0d5503460f94af6c33/html5/thumbnails/70.jpg)